Clinical Trials Browser

Phase 1 × gilteritinib × Thoracic × Clear all

NCT07140016 2026-03-04

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06225427 2025-10-20

Gilteritinib for the Treatment of ALK NSCLC

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms